FDA's Projected $20 Mil. In 2013 Biosimilar User Fees Translates Into 68 More Staffers
This article was originally published in The Pink Sheet Daily
Executive Summary
Administration’s proposed fiscal year 2013 spending plan includes $4.5 billion for FDA, with $2 billion or 44% provided by various user fees.